The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis

Combs, C.
Schuit, E.
Caritis, S.
Lim, A.
Garite, T.
Maurel, K.
Rouse, D.
Thom, E.
Tita, A.
Mol, B.

January 2016

Preterm birth complicates almost all triplet pregnancies and no preventive strategy has proven effec...

The Impact of Maternal Body Mass on the Effectiveness of 17 alpha-Hydroxyprogesterone Caproate

Ventolini, Gary
Duke, Janice
Po, William
Barhan, Sheela M.
Rhea, Debbie
Desch, Cheryl
Istwan, Niki
Stanziano, Gary

September 2008

OBJECTIVE: To examine the impact of maternal prepregnancy body mass index (BMI) on rates of recurren...

Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.

Lim, A.C.
Bloemenkamp, K.W.
Boer, K.
Duvekot, J.J.
Erwich, J.J.
Hasaart, T.H.M.
Hummel, P.
Mol, B.W.
Offermans, J.P.M.
Oirschot, C.M. van
Santema, J.G.
Scheepers, H.C.J.
Schols, W.A.
Vandenbussche, F.P.H.A.
Wouters, M.G.A.J.
Bruinse, H.W.

January 2007

Contains fulltext : 53264.pdf (publisher's version ) (Open Access)BACKGROUND: 15% ...

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

Gyamfi, Cynthia
Horton, Amanda L.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Meis, Paul J.
Spong, Catherine Y.
Dombrowski, Mitchell
Sibai, Baha
Varner, Michael W.
Iams, Jay D.
Mercer, Brian M.
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
O'Sullivan, Mary Jo
Miodovnik, Menachem
Conway, Deborah

January 2009

To compare the rates of gestational diabetes (GDM) among women who received serial doses of 17 alpha...

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Caritis, Steve N.
Simhan, Hyagriv N.
Zhao, Yuan
Rouse, Dwight J.
Peaceman, Alan M.
Sciscione, Anthony
Spong, Catherine Y.
Varner, Michael W.
Malone, Fergal D.
Iams, Jay D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall
Lo, Julie
Ramin, Susan M.
Harper, Margaret

January 2012

To evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (1...

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth

Caritis, Steve N.
Venkataramanan, Raman
Thom, Elizabeth
Harper, Margaret
Klebanoff, Mark A.
Sorokin, Yoram
Thorp, John M.
Varner, Michael W.
Wapner, Ronald J.
Iams, Jay D.
Carpenter, Marshall W.
Grobman, William A.
Mercer, Brian M.
Sciscione, Anthony
Rouse, Dwight J.
Ramin, Susan

January 2014

17-alpha hydroxyprogesterone caproate (17-OHPC) 250 mg weekly reduces recurrent spontaneous preterm ...

17-alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trial

Lim, A.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.
Duvekot, J.
Erwich, J.
van Eyck, J.
Groenwold, R.
Hasaart, T.
Hummel, P.
Kars, M.
Kwee, A.
van Oirschot, C.
van Pampus, M.
Papatsonis, D.
Porath, M.
Spaanderman, M.
Willekes, C.
Wilpshaar, J.
Mol, B.
et al.

January 2011

OBJECTIVE: To estimate whether administration of 17[alpha]-hydroxyprogesterone caproate can prevent ...

17 alpha-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies

Lim, Arianne C.
Schuit, Ewoud
Bloemenkamp, Kitty
Bernardus, Rob E.
Duvekot, Johannes J.
Erwich, Jan Jaap H. M.
van Eyck, Jim
Groenwold, Rolf H. H.
Hasaart, Tom H. M.
Hummel, Piet
Kars, Michael M.
Kwee, Anneke
van Oirschot, Charlotte M.
van Pampus, Marielle G.
Papatsonis, Dimitri N. M.
Porath, Martina
Spaanderman, Marc E.
Willekes, Christine
Wilpshaar, Janine
Mol, Ben W. J.
Bruinse, Hein W.

September 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

Does 17-alpha-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?

Mulder, E.
Versteegh, E.
Bloemenkamp, K.
Lim, A.
Mol, B.
Bekedam, D.
Kwee, A.
Bruinse, H.
Christiaens, G.

January 2013

ObjectiveIncreasingly, maternal administration of 17-α-hydroxyprogesterone caproate (17-OHPC) is uti...

17 alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.H.M.
van Eyck, J.
Groenwold, R.H.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
van Oirschot, C.M.
van Pampus, M.G.
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.
Willekes, C.
Wilpshaar, J.
Mol, B.W.J.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17 alpha hydroxyprogesterone caproate

Durnwald, Celeste P.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Varner, Michael W.
Malone, Fergal D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
Harper, Margaret
Spong, Catherine Y.

January 2010

To compare rates of preterm birth before 35 weeks based on cervical length measurement at 16-20 week...

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Andrei Rebarber Md
Niki B. Istwan
Karen Russo-stieglitz Md
Jane Cleary-goldman Md
Debbie J. Rhea
Gary J. Stanziano
Daniel H. Saltzman

October 2016

OBJECTIVE — Progesterone has a known diabetogenic effect. We sought to determine whether the inciden...

17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.
Eyck, J. van
Groenwold, R.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
Oirschot, C.M. van
Pampus, M.G. van
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.A.
Willekes, C.
Wilpshaar, J.
Mol, B.W.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17alpha-hydroxyprogesterone caproate can prevent ne...

Estimated Effect of 17 Alpha-Hydroxyprogesterone Caproate on Preterm Birth in the United States

Joann R. Petrini Phd
Karla Damus

January 2015

OBJECTIVE: A multicenter, randomized placebo-controlled trial among women with singleton pregnancies...

Vaginal progesterone compared to intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis

Boelig, Rupsa C
Locci, Mariavittoria
Saccone, Gabriele
Gragnano, Elisabetta
Berghella, Vincenzo

January 2022

Objective: Randomized trials have found benefit for both vaginal progesterone and 17-hydroxy progest...

17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis

Combs, C.
Schuit, E.
Caritis, S.
Lim, A.
Garite, T.
Maurel, K.
Rouse, D.
Thom, E.
Tita, A.
Mol, B.

January 2016

Preterm birth complicates almost all triplet pregnancies and no preventive strategy has proven effec...

The Impact of Maternal Body Mass on the Effectiveness of 17 alpha-Hydroxyprogesterone Caproate

Ventolini, Gary
Duke, Janice
Po, William
Barhan, Sheela M.
Rhea, Debbie
Desch, Cheryl
Istwan, Niki
Stanziano, Gary

September 2008

OBJECTIVE: To examine the impact of maternal prepregnancy body mass index (BMI) on rates of recurren...

Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.

Lim, A.C.
Bloemenkamp, K.W.
Boer, K.
Duvekot, J.J.
Erwich, J.J.
Hasaart, T.H.M.
Hummel, P.
Mol, B.W.
Offermans, J.P.M.
Oirschot, C.M. van
Santema, J.G.
Scheepers, H.C.J.
Schols, W.A.
Vandenbussche, F.P.H.A.
Wouters, M.G.A.J.
Bruinse, H.W.

January 2007

Contains fulltext : 53264.pdf (publisher's version ) (Open Access)BACKGROUND: 15% ...

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

Gyamfi, Cynthia
Horton, Amanda L.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Meis, Paul J.
Spong, Catherine Y.
Dombrowski, Mitchell
Sibai, Baha
Varner, Michael W.
Iams, Jay D.
Mercer, Brian M.
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
O'Sullivan, Mary Jo
Miodovnik, Menachem
Conway, Deborah

January 2009

To compare the rates of gestational diabetes (GDM) among women who received serial doses of 17 alpha...

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Caritis, Steve N.
Simhan, Hyagriv N.
Zhao, Yuan
Rouse, Dwight J.
Peaceman, Alan M.
Sciscione, Anthony
Spong, Catherine Y.
Varner, Michael W.
Malone, Fergal D.
Iams, Jay D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall
Lo, Julie
Ramin, Susan M.
Harper, Margaret

January 2012

To evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (1...

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth

Caritis, Steve N.
Venkataramanan, Raman
Thom, Elizabeth
Harper, Margaret
Klebanoff, Mark A.
Sorokin, Yoram
Thorp, John M.
Varner, Michael W.
Wapner, Ronald J.
Iams, Jay D.
Carpenter, Marshall W.
Grobman, William A.
Mercer, Brian M.
Sciscione, Anthony
Rouse, Dwight J.
Ramin, Susan

January 2014

17-alpha hydroxyprogesterone caproate (17-OHPC) 250 mg weekly reduces recurrent spontaneous preterm ...

17-alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trial

Lim, A.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.
Duvekot, J.
Erwich, J.
van Eyck, J.
Groenwold, R.
Hasaart, T.
Hummel, P.
Kars, M.
Kwee, A.
van Oirschot, C.
van Pampus, M.
Papatsonis, D.
Porath, M.
Spaanderman, M.
Willekes, C.
Wilpshaar, J.
Mol, B.
et al.

January 2011

OBJECTIVE: To estimate whether administration of 17[alpha]-hydroxyprogesterone caproate can prevent ...

17 alpha-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies

Lim, Arianne C.
Schuit, Ewoud
Bloemenkamp, Kitty
Bernardus, Rob E.
Duvekot, Johannes J.
Erwich, Jan Jaap H. M.
van Eyck, Jim
Groenwold, Rolf H. H.
Hasaart, Tom H. M.
Hummel, Piet
Kars, Michael M.
Kwee, Anneke
van Oirschot, Charlotte M.
van Pampus, Marielle G.
Papatsonis, Dimitri N. M.
Porath, Martina
Spaanderman, Marc E.
Willekes, Christine
Wilpshaar, Janine
Mol, Ben W. J.
Bruinse, Hein W.

September 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

Does 17-alpha-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?

Mulder, E.
Versteegh, E.
Bloemenkamp, K.
Lim, A.
Mol, B.
Bekedam, D.
Kwee, A.
Bruinse, H.
Christiaens, G.

January 2013

ObjectiveIncreasingly, maternal administration of 17-α-hydroxyprogesterone caproate (17-OHPC) is uti...

17 alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.H.M.
van Eyck, J.
Groenwold, R.H.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
van Oirschot, C.M.
van Pampus, M.G.
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.
Willekes, C.
Wilpshaar, J.
Mol, B.W.J.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17 alpha hydroxyprogesterone caproate

Durnwald, Celeste P.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Varner, Michael W.
Malone, Fergal D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
Harper, Margaret
Spong, Catherine Y.

January 2010

To compare rates of preterm birth before 35 weeks based on cervical length measurement at 16-20 week...

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

Andrei Rebarber Md
Niki B. Istwan
Karen Russo-stieglitz Md
Jane Cleary-goldman Md
Debbie J. Rhea
Gary J. Stanziano
Daniel H. Saltzman

October 2016

OBJECTIVE — Progesterone has a known diabetogenic effect. We sought to determine whether the inciden...

17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.
Eyck, J. van
Groenwold, R.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
Oirschot, C.M. van
Pampus, M.G. van
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.A.
Willekes, C.
Wilpshaar, J.
Mol, B.W.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17alpha-hydroxyprogesterone caproate can prevent ne...

Estimated Effect of 17 Alpha-Hydroxyprogesterone Caproate on Preterm Birth in the United States

Joann R. Petrini Phd
Karla Damus

January 2015

OBJECTIVE: A multicenter, randomized placebo-controlled trial among women with singleton pregnancies...

Vaginal progesterone compared to intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis

Boelig, Rupsa C
Locci, Mariavittoria
Saccone, Gabriele
Gragnano, Elisabetta
Berghella, Vincenzo

January 2022

Objective: Randomized trials have found benefit for both vaginal progesterone and 17-hydroxy progest...

17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis

Combs, C.
Schuit, E.
Caritis, S.
Lim, A.
Garite, T.
Maurel, K.
Rouse, D.
Thom, E.
Tita, A.
Mol, B.

January 2016

Preterm birth complicates almost all triplet pregnancies and no preventive strategy has proven effec...

The Impact of Maternal Body Mass on the Effectiveness of 17 alpha-Hydroxyprogesterone Caproate

Ventolini, Gary
Duke, Janice
Po, William
Barhan, Sheela M.
Rhea, Debbie
Desch, Cheryl
Istwan, Niki
Stanziano, Gary

September 2008

OBJECTIVE: To examine the impact of maternal prepregnancy body mass index (BMI) on rates of recurren...

Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.

Lim, A.C.
Bloemenkamp, K.W.
Boer, K.
Duvekot, J.J.
Erwich, J.J.
Hasaart, T.H.M.
Hummel, P.
Mol, B.W.
Offermans, J.P.M.
Oirschot, C.M. van
Santema, J.G.
Scheepers, H.C.J.
Schols, W.A.
Vandenbussche, F.P.H.A.
Wouters, M.G.A.J.
Bruinse, H.W.

January 2007

Contains fulltext : 53264.pdf (publisher's version ) (Open Access)BACKGROUND: 15% ...

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

Abstract

Extracted data

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

Abstract

Extracted data

Related items

Related items